From ‘Booster-For-All’ To ‘Pfizer-For-Some’: Lessons From The Third Shot Debate

 
• By Michael McCaughan
  
The White House, FDA, and CDC each took different approaches to the booster issue • Source: Nielsen Hobbs
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers